Ypsomed Holding AG
Research Ypsomed Holding AG (YPSN.SW) with Bullrun company financials, valuation charts, model signals, and historical stock context.
Key Metrics
- TickerYPSN.SW
- ExchangeSW
- CountrySwitzerland
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyCHF
- Financial periodFY2026
- RevenueCHF 730.98M
- Revenue growth-2.4%
- Net incomeCHF 221.93M
- Free cash flow-CHF 16.34M
- Gross margin43.0%
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | CHF 730.98M | CHF 221.93M | -CHF 16.34M | 43.0% | 16.3 | CHF 28.56M | CHF 260.77M | CHF 748.13M |
| FY2025 | CHF 748.87M | CHF 87.50M | -CHF 128.95M | 39.0% | 6.41 | CHF 36.50M | CHF 267.00M | CHF 679.69M |
| FY2024 | CHF 548.46M | CHF 78.37M | -CHF 32.09M | 40.0% | 5.74 | CHF 74.02M | CHF 256.00M | CHF 617.73M |
| FY2023 | CHF 497.46M | CHF 51.28M | -CHF 39.64M | 28.3% | 3.82 | CHF 25.22M | CHF 157.00M | CHF 562.33M |
| FY2022 | CHF 464.84M | CHF 23.11M | -CHF 41.72M | 24.5% | 1.83 | CHF 17.04M | CHF 267.00M | CHF 392.54M |
Dividend history
| Year | Dividends/share |
|---|---|
| FY2026 | 4.71 CHF |
| FY2025 | 2.39 CHF |
| FY2024 | 2 CHF |
| FY2023 | 2.12 CHF |
| FY2022 | 0.65 CHF |
About Ypsomed Holding AG
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication in Switzerland, Europe, North America, and internationally. The company offers various injection systems, such as pen injectors, auto-injectors, and wearable injectors, as well as other related services. It offers contract manufacturing of infusion sets and reservoirs.
Related stock research
Other Healthcare stocks
Frequently asked questions
What does Ypsomed Holding AG do?
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication in Switzerland, Europe, North America, and internationally. The company offers various injection systems, such as pen injectors, auto-injectors, and wearable injectors, as well as other related services. It offers contract manufacturing of infusion sets and reservoirs. The company markets its products to hospitals, doctors, pharmacies and patients via subsidiaries and distributors.